| Symbol | OKYO |
|---|---|
| Name | OKYO PHARMA LTD |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 55 PARK LANE, LONDON, X0 W1K 1NA |
| Telephone | 44 (0) 207 495 2379 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001849296 |
| Description | None |
Director Denoyer Bernard 🟢 acquired 3.5K shares (1 derivative) of OKYO Pharma Ltd (OKYO) at $1.85 Transaction Date: Jun 08, 2026 | Filing ID: 028134
Read moreDirector BRANCACCIO JOHN P 🟢 acquired 6.5K shares (1 derivative) of OKYO Pharma Ltd (OKYO) at $1.85 Transaction Date: Jun 08, 2026 | Filing ID: 028133
Read moreDirector Simon Willy Jules 🟢 acquired 6.5K shares (1 derivative) of OKYO Pharma Ltd (OKYO) at $1.85 Transaction Date: Jun 08, 2026 | Filing ID: 028132
Read moreShah Keeren Rameshchandra 🟢 acquired 40.0K shares (1 derivative) of OKYO Pharma Ltd (OKYO) at $1.85 Transaction Date: Jun 08, 2026 | Filing ID: 028131
Read moreDirector CERRONE GABRIELE M 🟢 acquired 300.0K shares of OKYO Pharma Ltd (OKYO) at $1.72 Transaction Date: Jun 08, 2026 | Filing ID: 028117
Read moreNew Form 3 - OKYO Pharma Ltd <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001493152-26-026927 <b>Size:</b> 16 KB
Read moreNew Form 3 - OKYO Pharma Ltd <b>Filed:</b> 2026-06-01 <b>AccNo:</b> 0001493152-26-026688 <b>Size:</b> 23 KB
Read moreNew Form 3 - OKYO Pharma Ltd <b>Filed:</b> 2026-06-01 <b>AccNo:</b> 0001493152-26-026685 <b>Size:</b> 26 KB
Read moreNew Form SCHEDULE 13G - OKYO Pharma Ltd <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0000919574-26-003227 <b>Size:</b> 9 KB
Read moreNew Form SCHEDULE 13G - OKYO Pharma Ltd <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0000919574-26-003208 <b>Size:</b> 14 KB
Read more